View More Recent Stories
-
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024
-
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024
-
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
-
Amphastar Pharmaceuticals (AMPH) PT Lowered to $55 at Jefferies
-
Amphastar Pharmaceuticals (AMPH) PT Lowered to $66 at Piper Sandler
-
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024
-
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024
-
10 policies if Trump wins and stock implications: Jefferies
-
Piper Sandler Reiterates Overweight Rating on Amphastar Pharmaceuticals (AMPH)
-
4 Buy-rated Healthcare stocks with 30-45% upside

